Skip to main content
. Author manuscript; available in PMC: 2024 Oct 1.
Published in final edited form as: Pain. 2023 Jun 6;164(10):2343–2351. doi: 10.1097/j.pain.0000000000002944

Table 1:

Sample demographics. UCPPS = urologic chronic pelvic pain syndrome. BFP− = bladder filling pain negative, BFP+ = bladder filling pain positive, intermed. = intermediate between BFP− and BFP+

Healthy Controls (N=72) UCPPS all. (N=429) UCPPS BFP− (N=109) UCPPS Intermed. (N=175) UCPPS BFP+ (N=145)
Age Mean (SD) 41.1 (14.8) 43.7(15.6) 46.4 (15.8) 42.6 (15.9) 42.8 (14.7)
Sex (F) N (%) 35 (48.6) 274 (63.8) 66 (60.5) 103 (58.9) 105 (72.4)*
Race N (%)
Caucasian 47 (65.3) 380 (88.6) 98 (89.9) 160 (91.4) 122 (84.1)
African American/Black 9 (12.5) 23 (5.4) 5 (5.5) 5 (2.9) 12 (8.3)
North American Indian/ Northern Native 0 (0) 2 (.5) 0 (0) 1 (.6) 1 (.7)
Native Hawaiian/Other Pacific Islander 0 (0) 1 (.2) 0 (0) 0 (0) 1 (.7)
Asian / Asian American 7 (9.7) 3 (.7) 1 (.9) 1 (.6) 1 (.7)
More than one race 6 (8.3) 15 (3.5) 3 (2.8) 6 (3.4) 6 (4.1)
other 3 (4.2) 5 (1.2) 1 (.9) 2 (1.1) 2 (1.4)
Ethnicity (Non-hispanic) N (%) 64 (88.9) 400 (93.2) 102 (93.6) 162 (92.6) 136 (93.8)
Duration of symptoms in years Mean (SD) N/A 11.4 (11.1) 11.4 (12.1) 11.1 (11.0) 11.7 (10.5)
*

p=.030 by Pearson’s chi-square test